OnKure grants director 7,650 stock options
OnKure Therapeutics director Andrew John Phillips received a grant of stock options covering 7,650 shares of Class A common stock at an exercise price of $4.30 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
OnKure Therapeutics director Andrew John Phillips received a grant of stock options covering 7,650 shares of Class A common stock at an exercise price of $4.30 per share. The options vest 100% on the earlier of June 4, 2027 or the day before the next annual stockholder meeting, contingent on his continued service, and expire on June 3, 2036.
Insider Trade Summary
Grant/Award: 7,650 shares
Grant/Award
1 txn
Insider
Phillips Andrew John
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 7,650 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 7,650 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option will vest on the earlier of June 4, 2027 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.
Key Figures
Options granted: 7,650 options
Exercise price: $4.30 per share
Expiration date: June 3, 2036
+1 more
4 metrics
Options granted
7,650 options
Stock Option grant to director on June 4, 2026
Exercise price
$4.30 per share
Exercise price for 7,650 stock options
Expiration date
June 3, 2036
Option term end date
Vesting date trigger
June 4, 2027 or before next annual meeting
100% cliff vesting condition, subject to continued service
Key Terms
Stock Option (right to buy), Class A Common Stock, vesting, annual meeting of stockholders
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vesting financial
"100% of the shares subject to the option will vest on the earlier of June 4, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"or the day prior to the date of the Issuer's next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did OnKure Therapeutics (OKUR) report for Andrew John Phillips?
OnKure reported that director Andrew John Phillips received a grant of 7,650 stock options. These options allow him to buy Class A common shares at a fixed $4.30 exercise price as part of his equity-based compensation package.
What are the key terms of Andrew John Phillips’ 7,650 OnKure (OKUR) stock options?
The option grant covers 7,650 shares of Class A common stock at a $4.30 exercise price. All options vest together on the earlier of June 4, 2027 or the day before the next annual stockholder meeting, and expire on June 3, 2036.
When do the newly granted OnKure (OKUR) stock options to Andrew John Phillips vest?
All 7,650 options vest 100% on the earlier of June 4, 2027 or the day prior to OnKure’s next annual stockholder meeting. Vesting is conditional on Phillips continuing as a service provider through the applicable vesting date.
Is Andrew John Phillips’ OnKure (OKUR) option grant an open-market purchase or compensation award?
The Form 4 characterizes the transaction as a grant or award acquisition, not an open-market purchase. It is a stock option compensation award with a $4.30 exercise price, granted to Phillips in his capacity as a director.
How long does Andrew John Phillips have to exercise his OnKure (OKUR) stock options?
The stock options expire on June 3, 2036, giving Phillips up to roughly ten years from grant to exercise. However, he must satisfy the vesting requirement, continuing as a service provider until vesting occurs, before exercising them.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates